Figures from this source
- FiledFx gain loss nonop net, year to March 2017
- FiledEquity method investment income, year to March 2017¥20.3bn
- FiledOci fx translation adjustment, year to March 2017−¥5.9bn
- FiledOci securities valuation difference, year to March 2017¥7.1bn
- FiledOci equity method share, year to March 2017¥711m
- FiledBs fx translation adjustment balance, year to March 2017−¥30.3bn
- FiledNet sales, year to March 2017¥489.1bn
- FiledOperating income, year to March 2017¥29.4bn
- FiledOrdinary income, year to March 2017¥50.4bn
- FiledFx gain loss nonop net, year to March 2016
- FiledEquity method investment income, year to March 2016¥1.9bn
- FiledOci fx translation adjustment, year to March 2016−¥15.4bn
- FiledOci securities valuation difference, year to March 2016−¥4.7bn
- FiledOci equity method share, year to March 2016−¥97m
- FiledBs fx translation adjustment balance, year to March 2016−¥25.3bn
- FiledNet sales, year to March 2016¥504.5bn
- FiledOperating income, year to March 2016¥32.9bn
- FiledOrdinary income, year to March 2016¥28.8bn
- FiledInvestment securities in nonconsolidated subs and associates carrying, year to March 2016¥11.6bn
- FiledInvestment securities in nonconsolidated subs and associates carrying, year to March 2017¥25.3bn
- FiledOverseas sales ratio, year to March 201773.4%
- FiledOverseas sales, year to March 2017¥359bn
- FiledAssociates combined net income 100%, year to March 2017 (4 associates incl. TPC)¥42bn
- FiledAssociates combined net sales 100%, year to March 2017 (4 associates incl. TPC)¥166.1bn
- FiledAssociates combined net assets 100%, year to March 2017 (4 associates incl. TPC)¥56.7bn